Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: LLC ARENSIA Exploratory Medicine Tbilisi, Georgia

IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova

Hospital Beata Maria Ana Madrid, Spain

Hospital Fundación Jiménez Diaz Madrid, Spain

View Trial Details

Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

NCT07439653

Conditions: Hemic and Lymphatic Diseases, Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, Immune System Diseases, +8 more
Locations: UCLA Santa Monica, California, United States

Stanford University Stanford, California, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

NCT07558538

Conditions: ARDS (Acute Respiratory Distress Syndrome), ARDS (Moderate or Severe), Acute Lung Injury, +13 more
Locations: ShanghaiZhongshan Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

CD45BE-HSPC + CART-45 Cells

NCT07451054

Conditions: B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT06594640

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Institute of Hematology & Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma

NCT07555470

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

NCT06745583

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: Taipei Veterans General Hospital Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Recruiting

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT04892277

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

NCT07234162

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Anhui Provincial Cancer Hospital Hefei, Anhui, China

The Second Hospital of Anhui Medical University Hefei, Anhui, China

Beijing Hospital Beijing, Beijing Municipality, China

Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China

View all 51 locations

View Trial Details